User:Mr. Ibrahem/Pimavanserin

Pimavanserin, sold under the brand name Nuplazid, is an medication used to treat psychosis in Parkinson's disease. It is not recommended for psychosis due to dementia. It is taken by mouth.

Common side effects include swelling and confusion. Other side effects may include QT prolongation. Use in not recommended in those with liver problems. It is an atypical antipsychotic. How it works is not clear but may involved effects on serotonin receptors.

Pimavanserin was approved for medical use in the United States in 2016. It is not approved in Europe or the United Kingdom as of 2021. In the United States it costs about 4,200 USD per month as of 2021.